ClinicalTrials.gg
RecruitingNCT05729542Updated Feb 10, 2026

Comparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries

An interventional study of Arthrex Tightrope and Synthes Fibulink in Ankle Injuries, Syndesmotic Injuries and Ankle Fractures, sponsored by University of California, San Diego. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-10.

Primary conditionAnkle FracturesRegistry: Ankle InjuriesReclassifiedWhy we changed it
Registry
Ankle Injuries — the first condition term the registry derived for this study.
ClinicalTrials.gg
Ankle Fractures
Why
  1. The study's listed conditions name Ankle Fractures, a narrower term within Ankle Injuries.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Nov 2021, registered Feb 2023).
  • Started Nov 2021; still recruiting 5 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 60 studies in Ankle Fractures with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Ankle Fractures · United States.

Planned enrollment
12th of 49
140 · median 55
Started
2021
with 5 others
No phase
37 of 60
13 open now
Primary completion
2026-12
later than 5 of 19 live
Registered
50th of 60
by date

Among the 60 studies in Ankle Fractures with a site in United States, this one is the 12th largest by planned enrollment of the 49 interventional ones that give a count, is one of 6 that started in 2021, is one of 37 with no phase, reaches primary completion later than 5 of the 19 other live ones, and was the 50th registered.

Ankle Fractures

203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.

Browse Ankle Fractures studies →

Open to participants now

16 of the 60 studies in Ankle Fractures with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 60 studies in Ankle Fractures with a site in United States, or all of them as a file.
02

Study summary

This project consists of a randomized controlled study design. Study candidates will include all patients 18 years or older, who were evaluated at UCSD and found to have an acute ankle syndesmosis injury requiring surgery. Patients who consent to study participation will be randomized to receive one of two standard of care procedures - either a suture button or Fibulink implant. Outcome measures, including the Olerud-Molander and American Orthopaedic Foot and Ankle Society scores, pain, range of motion, time to return to work, and radiographic evaluation will be collected for each participant. Given the potential degenerative changes and poor radiographic and clinical outcomes with inadequate repair of the syndesmosis, it is imperative to evaluate existing and emerging methods of fixation for patients with acute ankle fractures with syndesmosis injuries.

03

Conditions studied

  • Ankle Injuries
  • Syndesmotic Injuries
  • Ankle Fractures

Browse trials for

04

In context

Ankle Fractures Reclassified

203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.

This study's planned enrollment of 140 is above the median of 90 across 151 interventional studies indexed under Ankle Fractures.

Browse Ankle Fractures studies →

Lead sponsor

University of California, San Diego is the lead sponsor of 980 studies on the registry; 194 are open to participants now.

Of its 113 completed or terminated interventional studies of FDA-regulated products, 71 (63%) have results posted.

Compared within Ankle Fractures, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Ankle Injuries. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ankle fracture with associated syndesmotic injury requiring surgery
  • Age 18 years or older
  • Ability to understand the content of the patient information/ form

Exclusion criteria

Exclusion Criteria:

  • Any not medically managed severe systemic disease
  • Patient preference for specific implant
  • Refusal of randomization
  • Pregnant patients
  • Prisoners
  • Participation in any other pharmacologic or medicinal product study within the previous month that could influence the results of this study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
140 participants (estimated)

Study arms

  • Active comparator
    Arthrex Tightrope

    Syndesmosis fixation performed with ARthrex Tightrope device. This is a high-tension suture fixation with a button based anchor system.

    Device: Arthrex Tightrope

  • Experimental
    Synthes Fibulink

    Syndesmosis fixation perforemd with Synthes Fibulink device. This is a high-tension fixation with a screw based anchor system.

    Device: Synthes Fibulink

Interventions

  • DeviceArthrex Tightrope

    High-tensile strength suture syndesmosis repair

  • DeviceSynthes Fibulink

    High-tensile strength suture syndesmosis repair

07

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS) Pain score

    VAS Pain score is rated from 0-10, 0=no pain and 10=most severe pain

    Time frame: 1 year

  2. Foot and Ankle Disability Index

    Functional score with a 0-104 with higher scores indicating better function

    Time frame: 1 year

  3. Olerud-Molander Ankle Score

    Functional Score with a score of 0-100 with higher scores indicating better function

    Time frame: 1 year

Secondary outcomes

  1. Number of participants with medical or surgical complications

    Medical and surgical complications to include: surgical site infection, re-operation, device failure, loss of motion

    Time frame: 1 year

08

Study locations

1 of 1 sites recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2021 (actual). Primary completion is estimated for Dec 2026, 61 months after the start.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 61 months is above that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2023
First posted
Feb 15, 2023
StartActual
Nov 18, 2021
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Feb 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05729542
Responsible party
William Kent (Assistant Professor of Orthopaedic Surgery, University of California, San Diego) — Principal investigator
First posted
Feb 15, 2023
Start date
Nov 18, 2021
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Feb 10, 2026

Study contacts

Dominic Baun, MS
Contact
jbaun@health.ucsd.edu
858-534-8268
William Kent, MD
Contact
wkent@health.ucsd.edu
619-543-2694

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion